EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation

Seemal R Desai, Edward Ted Lain, Nada Elbuluk, Cheri Frey

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.9517 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Seemal R Desai und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hyperpigmentation, Resorcinols, Facial Dermatoses.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperpigmentationResorcinolsFacial DermatosesHumansFemaleMaleMiddle AgedAdultTreatment OutcomeFaceSkin PigmentationAgedSkin CreamAdministration, CutaneousYoung Adult

Substanzen

Resorcinols

Zitieren

APA

Desai, S. R., Lain, E. T., Elbuluk, N., & Frey, C. (2025). Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9517

Vancouver

Desai SR, Lain ET, Elbuluk N, Frey C. Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9517

BibTeX
@article{Desai2025,
  author = {Desai, Seemal R and Lain, Edward Ted and Elbuluk, Nada and Frey, Cheri},
  title = {Clinical Evaluation of Thiamidol-Containing Formulations for the Visual Management of Facial Hyperpigmentation},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.9517}
}
Kostenlos starten →